BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

795 related articles for article (PubMed ID: 11742411)

  • 1. beta-Cell death during progression to diabetes.
    Mathis D; Vence L; Benoist C
    Nature; 2001 Dec; 414(6865):792-8. PubMed ID: 11742411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice.
    Pang S; Zhang L; Wang H; Yi Z; Li L; Gao L; Zhao J; Tisch R; Katz JD; Wang B
    Eur J Immunol; 2009 Oct; 39(10):2716-24. PubMed ID: 19658094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caspase-3-dependent beta-cell apoptosis in the initiation of autoimmune diabetes mellitus.
    Liadis N; Murakami K; Eweida M; Elford AR; Sheu L; Gaisano HY; Hakem R; Ohashi PS; Woo M
    Mol Cell Biol; 2005 May; 25(9):3620-9. PubMed ID: 15831467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell responses to islet antigens improves detection of autoimmune diabetes and identifies patients with more severe beta-cell lesions in phenotypic type 2 diabetes.
    Goel A; Chiu H; Felton J; Palmer JP; Brooks-Worrell B
    Diabetes; 2007 Aug; 56(8):2110-5. PubMed ID: 17473222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interleukin-1 and nitric oxide involved in the pathogenesis of diabetes)].
    Sjöholm A
    Lakartidningen; 1999 May; 96(19):2338-41. PubMed ID: 10377681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the pathogenicity of autoantigen-specific T-cell receptors.
    Burton AR; Vincent E; Arnold PY; Lennon GP; Smeltzer M; Li CS; Haskins K; Hutton J; Tisch RM; Sercarz EE; Santamaria P; Workman CJ; Vignali DA
    Diabetes; 2008 May; 57(5):1321-30. PubMed ID: 18299317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The accelerator hypothesis and increasing incidence of type 1 diabetes.
    Fourlanos S; Harrison LC; Colman PG
    Curr Opin Endocrinol Diabetes Obes; 2008 Aug; 15(4):321-5. PubMed ID: 18594271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological reversal of autoimmune diabetes without hematopoietic replacement of beta cells.
    Suri A; Calderon B; Esparza TJ; Frederick K; Bittner P; Unanue ER
    Science; 2006 Mar; 311(5768):1778-80. PubMed ID: 16556846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4+CD25+ regulatory T cells control the progression from periinsulitis to destructive insulitis in murine autoimmune diabetes.
    Ott PA; Anderson MR; Tary-Lehmann M; Lehmann PV
    Cell Immunol; 2005 May; 235(1):1-11. PubMed ID: 16122720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of spontaneous autoimmune diabetes is associated with a switch in the killing mechanism used by autoreactive CTL.
    Qin H; Trudeau JD; Reid GS; Lee IF; Dutz JP; Santamaria P; Verchere CB; Tan R
    Int Immunol; 2004 Nov; 16(11):1657-62. PubMed ID: 15466911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerogenic strategies to halt or prevent type 1 diabetes.
    Cooke A; Phillips JM; Parish NM
    Nat Immunol; 2001 Sep; 2(9):810-5. PubMed ID: 11526391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular mechanisms of beta-cell destruction in type 1 diabetes].
    Mandrup-Poulsen TR
    Ugeskr Laeger; 2001 Aug; 163(32):4176-9. PubMed ID: 11510233
    [No Abstract]   [Full Text] [Related]  

  • 13. TRPV1+ sensory neurons control beta cell stress and islet inflammation in autoimmune diabetes.
    Razavi R; Chan Y; Afifiyan FN; Liu XJ; Wan X; Yantha J; Tsui H; Tang L; Tsai S; Santamaria P; Driver JP; Serreze D; Salter MW; Dosch HM
    Cell; 2006 Dec; 127(6):1123-35. PubMed ID: 17174891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C. L. Oakley lecture (1987). The pathogenesis of beta cell destruction in type I (insulin-dependent) diabetes mellitus.
    Foulis AK
    J Pathol; 1987 Jul; 152(3):141-8. PubMed ID: 3309229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preservation of beta-cell function during immune-mediated, B7-1-dependent alpha-cell destruction.
    Skak K; Haase C; Michelsen BK
    Eur J Immunol; 2005 Sep; 35(9):2583-90. PubMed ID: 16078275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of residual beta cells and islet autoimmunity during increasing duration of diabetes in NOD mice and experimental approaches toward reversing new-onset disease with bioactive peptides.
    Reddy S; Cheung CC; Chai RC; Rodrigues JA
    Ann N Y Acad Sci; 2008 Dec; 1150():171-6. PubMed ID: 19120289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of pancreatic beta-cell destruction in type I diabetes.
    Nerup J; Mandrup-Poulsen T; Mølvig J; Helqvist S; Wogensen L; Egeberg J
    Diabetes Care; 1988; 11 Suppl 1():16-23. PubMed ID: 3069387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmunity triggers in the NOD mouse: a role for natural auto-antibody reactivities in type 1 diabetes.
    Côrte-Real J; Duarte N; Tavares L; Penha-Gonçalves C
    Ann N Y Acad Sci; 2009 Sep; 1173():442-8. PubMed ID: 19758184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. beta cell-specific CD4+ T cell clonotypes in peripheral blood and the pancreatic islets are distinct.
    Li L; He Q; Garland A; Yi Z; Aybar LT; Kepler TB; Frelinger JA; Wang B; Tisch R
    J Immunol; 2009 Dec; 183(11):7585-91. PubMed ID: 19917704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular mechanisms of pancreatic beta-cell destruction in type 1 diabetes].
    Isotani H; Hanafusa T
    Nihon Rinsho; 2002 Jul; 60 Suppl 7():383-7. PubMed ID: 12238077
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 40.